Filter
364
Text search:
guidelines
for
pharmacovigilance
Featured
46
112
Language
Document type
176
70
44
33
25
7
4
3
1
1
Countries / Regions
22
15
14
13
13
13
13
10
10
9
8
8
8
7
7
7
5
5
5
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
187
41
9
8
6
6
6
Toolboxes
45
44
32
30
21
17
13
5
2
2
2
1
1
1
1
1
1
The purpose of these guidelines is to help health workers to participate in the process of continuous surveillance of safety and efficacy of the pharmaceutical products which are used in clinical practice, thus help to achieve the ultimate goal to m
...
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious
...
The safety of medicines in Zambia - why health workers need to take action | Produced by the National Pharmacovigilance Unit (NPVU)
Therapeutics Information and Pharmacovigilance Centre | TIPC
DNDi is now striving to make fexinidazole available to the majority of people who have T.b. gambiense sleeping sickness. We are supporting a three-year access and pharmacovigilance study that began in 2020 and have so far carried out in-coun
...
Reporting system for the general public - This document aims to provide practical guidelines on how to set up national systems for consumers to rep
...
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR
...
Document No. : FDA/SMC/SMD/GL-RAR/2013/01
Made under Section 5 (c) of the Tanzania Food, Drugs and Cosmetics Act, 2003 | Second Edition
Accessed November, 2017
PMPB/INS-GUIDE/02
Document No. : FDA/SMC/SMD/GL-SMP/2015/05 |
These guidelines are for information, guidance and strict compliance by Marketing Authorization Holders and Local Representatives of regulated products
...
Fourth Edition
